Building the Largest Health Data Ecosystem in the US | Datavant CEO Kyle Armbrester
41m 56s
Healthcare remains a uniquely inefficient industry, riddled with administrative chaos, data silos, and opaque billing processes. Kyle Armrester, CEO of DataVont, addresses this through a scalable, secure, and patient-centric digital health data ecosystem. DataVont bridges clinical data gaps across providers, payers, life sciences, and legal firms by acting as a neutral, consent-driven intermediary, enabling real-time, interoperable data exchange without storing or monetizing data. This digital transformation reduces administrative burden by shifting data processing upstream—before claims are generated—allowing early clinical insights and better care coordination. With over 80,000 provider locations and 350 data partners, DataVont is now a central hub for health data. The company also tackles critical issues like data misuse and underutilization, driven by antiquated systems and weak cybersecurity. Kyle argues for urgent reforms to HIPAA and federal regulations to modernize data governance and incentivize patient-centered innovation. He highlights that value-based care and clinical EHRs must shift from billing-focused to patient-centered models, and that emerging tools like ambient scribing hold promise but require deeper integration and trust. Ultimately, the future of healthcare depends on dismantling systemic constraints, fostering trust, and aligning incentives—especially through bold policy and market innovation—to deliver better outcomes and reduce burnout.
Health cares the only industry where you go in, you have no idea what you're gonna pay,
you have no idea when the bill's gonna come, and there's a million different ping-pong balls
that go on in the middle with payers and secondary payers until that actually gets sorted out.
What if all that could be done right when clinical data is captured, and so day-to-day
advance powering that in a big way?
Today on the show, I talked to the CEO of one of the largest, most successful health tech
companies that most people don't know about.
I'm Halle Teco, the creator and co-host of this show.
If you enjoy listening to the Heart of Healthcare, then I think you'll enjoy my upcoming book,
Massively Better Healthcare.
The book shows you how to spot opportunities for meaningful change and turn obstacles into
your competitive advantage.
You'll learn about who really holds power in healthcare, and strategies for bending the
system without being broken by it.
Massively Better Healthcare is out very soon, and you can pre-order it on Amazon.
Welcome to The Heart of Healthcare Podcast.
I'm Halle Teco.
I'm Michael Eskadell, and I'm Steve Krause, and every Monday we bring you the latest in
healthcare innovation as we sit down with entrepreneurs and industry experts.
So buckle up and join us as we figure out how to improve healthcare for all.
Hello listeners, and welcome back to the show.
Today, we're talking with my friend, Kyle Armrester.
He is the CEO of DataVont, the largest health data ecosystem in the U.S. Previously, he
was CEO of Signify, which he led through its 2021 IPO, and later it's $8 billion acquisition
by CVS in 2023.
Before that, he spent seven years at Athena Health on strategy, corporate development, and
product teams.
Kyle, welcome to the show.
Thank you.
So great to be here.
You have literally been on every side of business.
You've grown companies, you've worked on strategy, product, IPOs, getting acquired, making
acquisitions, probably like the most diverse background of anyone I've ever known.
Can you tell our listeners how you ended up in healthcare in the first place what drew
you into this industry?
Yeah, absolutely.
I was kind of a pure technologist for a long time, and loved tackling complex problems
with technology, especially where there were areas of administrative burden or inefficiency.
So I could see something could be automated or streamlined, and there's plenty of that
to do in healthcare, oh, without a doubt.
But what really drew me towards healthcare was I was actually helping Charlie Baker with
his gubernatorial campaign in Massachusetts, just volunteering and doing a lot of the tech
infrastructure for him.
It just sold a pure tech company and wanted to get involved and help him out.
I met him through someone that was very close to, and he introduced me to Jonathan Bush,
who was CEO of Athena Health at the time, and I didn't know quite what to make of healthcare.
I was at HBS, and Athena was a mile down the road, and so I started spending more time
with Jonathan, and then around that same time, my grandmother, who was very, very close
to, and my father, both ended up passing away, and I got thrown into the middle of trying
to put information out of meta-tech and reconciling med lists, trying to coordinate end-of-life
care hospice from my grandmother in particular, and it was just absolute chaos.
And so it was serendipitous almost, if you will, to have had this introduction to Jonathan
and the team of Athena, who were trying to spread the cloud-based, you know, Jonathan
called it the Internet of Healthcare at the time, from a really small and medium business
standpoint up to bigger enterprises and scaling tech and product, and this whole open API mindset
that we built out there.
And so, yeah, it all came together really in a short amount of time, and that was a very
long time ago, and I've since then decided to dedicate the rest of my career and there's
my life towards moving the ball forward in the healthcare space and in particular in
technology.
Athena Health has such a notable diaspora, including yourself, the park brothers, an entire
generation of healthcare leaders that have gone on and done really interesting things.
So was it like working there and working for Jonathan Bush, who is kind of, he's a very
influential, but he's also a polarizing leader.
Yeah, it was, it was the most wild time of my career, I'm not sure if you were obligated.
We owned a mountain and main, you know, we did big conferences up there with 160 cabins
on it.
I mean, it was. We're not busy.
He's running, you know, running for governor of Maine.
For governor.
Yeah, that's right.
Yeah, it's funny how that all comes around, but yeah, it was, you know, what I will say
about my time at Athena, we were genuinely in the cappard seat of this kind of, the internet
exploding, but also healthcare kind of catching up, meaningful use, which was the democratization
of government funded democratization of electronic medical records across the whole country.
All these things were converging at once and so, you know, we were, we were the cool kids
on the street.
We could get a meeting with anybody and it was an amazing opportunity for me just to meet
so many folks doing so many amazing things.
When I started off there, as you mentioned, in corporate development and running more
disruption pleas, which was our big partner API program, and I probably met a thousand
companies in the first few years.
And they were all looking for rails, right, like minutes, unfortunately, still quasi-similar
today, but medical records and practice management systems are barbarians at the gate, like
you have to get through them to give them to the provider space, certainly, and you need
to use them to get information out, which is, we'll talk about data vent in a minute.
But it was, it was awesome.
And Jonathan had this mindset where he didn't want to do everything, right, so it was kind
of almost the opposite of some of the other players in the space.
But he wanted to open up and allow entrepreneurs, and I think he was scarred as a younger entrepreneur
for a lot of people shutting the door on him and saying, no, he wanted us to not be that
way.
And that mindset is something I certainly took away.
The second thing I would say is, you know, Jonathan and Ed, in particular, just maniacally
focused on the fact that physician cost was basically rising at the rate of inflation,
but administrative cost was rising at, you've seen that chart multiple times that rate.
And let's protect the physician.
Let's not charge them money for not adding value, and let's instead attack that bloat.
And that's something I've kept close to my chest through every company I've done, you
know, even signify and data vent, like do not believe in charging clients in healthcare
just fees for no reason, like you have to be there saving the money or making the money
or adding some value that's, you know, driving real benefit to them.
I just don't think that a traditional SaaS platform fee where you kind of hope and hand
a wave and argue about attribution works.
And so I really took that away from my time at Athena.
And the last thing I would say was just a wild focus on talent.
I mean, we had one of the best teams ever and just spent, you alluded to it, but so much
time recruiting and nurturing talent.
And I've taken that with me to each and every one of my companies.
And I still have a gang of folks that were at Athena, then signify an hour at data vent,
you know, with me.
I questioned their mental health every once in a while, just stayed with me this long.
They need a sabbatical.
Yeah, exactly.
But, you know, it's, it's fun, like, you know, people talk about blind passing and there
was a lot of that at Athena and this group that has exploded all across healthcare and
landscape.
There's a lot of trust in assuming positive regard is something we talked a lot about.
And I brought that to all my companies, since then.
I think for our listeners, anyone who wants to know a little bit more about the Athena
health story, I actually really enjoy Jonathan Bush's book, Where Does It Hurt is really
interesting.
And this was really one of the early, like, innovative technology companies in the space.
So I think a lot to learn and really cool to just see folks leave, stay within healthcare
and continue to take those lessons and make an impact.
So on that note, let's talk about DataVent.
As you know, I've had a plus one ticket to watching this organization grow and evolve.
My husband's been on the board for a decade yet.
I don't think.
Literally a decade.
Literally a decade.
Very cool.
I don't think I could actually, like, confidently pitch the company beyond just like this data
ecosystem.
Can you explain what you guys do for a lay audience, like what problem you're solving and
how you're solving it?
Yeah.
I mean, at the crux of what we do is a problem I have not solved.
You know, I'll just go back to some of the root issues that we're trying to move past.
When medical records were implemented, the one thing that they did not put in place was
an operability standards or common data frameworks or, you know, like, the ATM networks have
star and nice.
Like, you can go to an ATM and London or New York, pop a card in, and it's going to hit
your account.
Like, no matter who owns the ATM, no matter what card you're using, that type of infrastructure
doesn't exist in healthcare.
And so that is caused an unbelievable amount of administrative burden.
And in particular, I would say the one thing that happened and it was really exacerbated
was we had already, because medical records were paper-based for so long, this whole crazy
world of claims and all this like post-billing chaos kind of crept up and was digitized
before the medical record was to deal with payment, right?
And so when medical records came into the space, they were focused on payment.
And Athena Health was very much that way, right?
And you have these weird asoteric terms like CPT code and DRG and groupers and all these
other things that have really governed and dominated the way that medical, clinical,
financial, all data has been moved around inside the healthcare space.
And I think at its core, DataMan is trying to break away from those kind of legacy infrastructure
constraints and move us into an age where digital real-time, secure and compliant health
information is exciting.
with authorization and consent to anyone who wants it.
You know, in a nutshell, what we've done,
there was a department inside the hospitals
and health systems and clinics that has existed
for 40 plus years called the HIM department,
the Health Information Management Department.
And it started off with fax machines
and mailing medical records around 'cause there was again,
there is no digital interchange.
And what DataVan has become is that standard.
You know, we are the digital interchange
for clinical data in particular across,
really the entire healthcare ecosystem,
whether it's providers, health insurance companies,
life sciences companies, legal and attorney,
and even patients.
And what's happened, you know, the last several years,
when I started off, we were about 20% digital.
This over the last two years in particular,
we're now at about 55% digital.
And so we've shown up with a bunch of engineers,
redone incentives, and really pushed out a digital first
mindset, let's say two things are happening.
One, it is opening up you use cases.
And so, you know, all that chaos, that billing
and all the stuff that I mentioned
that sits downstream, it's actually starting to move upstream.
And administrative burden is going away as a result of that.
And I'll even be more specific.
Companies like SmarterDX, which is a sister portfolio
company of ours, they are moving way upstream
to value chain on doing coding and clinical data
information edits before anything goes to downstream revenue
cycle, claims, editing, et cetera.
And what's happening in effect is like so much of that
bloat on the backside, because again,
healthcare's the only industry where you go in,
you have no idea what you're going to pay.
You have no idea when the bill is going to come.
And there's a million different ping-pong balls
that go on in the middle with payers and secondary payers
that until that actually gets sorted out.
What if all that could be done right when
clinical data is captured?
And so data is powering that in a big way.
The second thing I would say, as we digitize,
our other customers are expanding their use cases too.
And so instead of just using us for traditional population
health or risk adjustment use cases,
we're now seeing vast quality programs, clinical trial
recruitment, we've tokenized a lot of the data,
which means we've linked and connected the data
to other desperate data sets, 350 real-world data
partners with a de facto standard in the space.
Like, what would another data partner?
Is it other EHRs or other sources of the data?
- Yeah, EHRs are a big one.
And we just announced that we're helping Athena Health
going back to my roots tokenize their data.
They've got it all in a snowflake instance.
But it's really everything under the sun.
It is labs, genomic companies, it's claims.
So that legacy payment information, it's other EHRs,
it is pharmaceutical companies, it's payers,
it's consumer companies.
And we have the ability to identify and de-identify
that data always with authorization and consent.
Again, at the course, we're doing it securely privately.
And so I guess, zooming back out,
we're leading the digital connectivity revolution
in healthcare and opening up more use cases.
But in doing so, we are killing
administrative burden at scale.
And really knocking, where we win
is when call centers go away or fax machines go away.
Or all these things that should never exist
and just put friction back on them.
But ultimately, the consumer in healthcare
and just really quick on a sense of scale,
we're in about half of all the hospitals
and health systems and clinics in the country.
And we do the majority of all payer and life sciences volume
that are sitting there asking and wanting that data.
And we sit uniquely in the middle of that supply and demand.
And so we have a data collaboration platform
that can view both sides of the ledger.
And as you said, you work with nearly every healthcare stakeholder
in terms of your working with providers, payers,
life science, maybe you can just tell us giving those three
examples and any other customer segments you want to add.
Like what is the key value proposition?
Because obviously what a payer is coming to you for
is very different from a life science company.
- Yeah, and that's the trick.
Like you nailed it.
We, to digitize, you have to see both sides, right?
Because it's not enough to just digitally enable the source
because the demand side system has its own requirements
and its own use cases, and you are absolutely right, every single
one of them is nuance.
And where we drive a lot of values through the curation
and finished product work that we do around the data
and connecting those to the supply and demand.
Second, there's a lot of tension
between these healthcare stakeholders, right?
Like a health insurance company and a provider,
like there's frequently tension between the two.
- Lots of finger pointing.
- Yes.
They actually need a neutral third party to sit in the middle
and just neutrally blindly using consent authorization
so making sure we have all the boxes checked.
75 plus steps in some states.
Like it's a really onerous, rightfully so process.
And that's where we set to.
So we're a neutral arbiter of all this information.
Just move it from point A to point B
and we do a ton of transformation
and build all the rails out to enable all that transformation.
But we actually don't have agency, right?
And we're not selling data, right?
We don't like go and buy data, market up and resell it.
Folks, you don't even store it, right?
You're not storing data.
- No, we keep it in our client's native environment,
which is what they're demanding, right?
We've actually done a lot of work with Amazon,
Databricks, and Snowflake in particular and others,
Azure, and et cetera, to enable our services
to be launched natively inside any environment.
And what's happened is you don't need to build
some master data warehouse or master patient index anymore
that's what's happened with the token and our digitization.
You're able to put technology natively
in your environment and connect securely,
completely with consent authorization
to all these other environments.
And some in once you have consent and not the right data
to solve the problems that you need.
The last thing I'll say,
we do play a heavy hand in contract management.
And so it's not enough to just neutrally facilitate.
They also need a vehicle for payment
and to hold contracts, data use rights,
like all of these things.
And we do all of that neutrally,
like we don't get involved in the negotiation.
But we make sure that it's seamless for folks
to engage in data exchange when they have consent
and off as a part of joining our data collaboration platform.
- And I mean, data on as a B2B company,
but most people don't realize you do have a consumer product,
you have a white label product that providers can use
for their patients.
Can you talk a little bit about that?
- Yeah, absolutely.
Right when I came on one of the first decisions
that I in the board made
was to make that product completely free.
And so there is a ton of consumer demand, you know,
anything from, I need a school form filled out
for my kids and a medical record attached to it,
to hey, I'm changing hospitals or I'm moving,
or I need to go see another specialist
and take my record with me.
There's a million different use cases.
And we can facilitate all that.
We have a digital interface for folks
to get their information.
They don't have to go down to the HIM department
that I described earlier.
Instead, they can interface with us digitally
and spend a huge success.
It's a bit of a big win for the industry too.
- And you guys don't take any credit for it.
You're not like building consumer brand recognition
'cause you're allowing the providers
to kind of take that credit from that product.
- Yeah, that's exactly right.
And I say this to everybody
and all of our client segments know this,
but the providers who we serve
are our most sacred kind of asset, right?
And they perform the medical care.
They have the patients and we work in partnership with them,
right?
It's their data and their patients data, not our data.
And you're absolutely right.
We work with them and their brands,
especially in their communities to help drive that.
Another interesting fact.
We are one of the largest consumers.
We are the largest consumer of Epic's Fire APIs.
We also push and help enroll a lot of folks into my chart.
Right, we're not competing with my chart.
My chart's a great place to go chat with your doctor,
see a result, right, if you just had a test or a lab done.
What we provide is again, access to the comprehensive
medical records, you can move it around
and digitize it and move it all over the place
and move it into any system you need to, not just Epic.
And so we're very complimentary
and Epic spent a great partner of ours for many years
and we spent a lot of time with them
building out digital connectivity across the landscape.
- Can you give our listeners an idea of the skill
that you guys are at right now?
Are there any numbers that you can share?
- Yeah, absolutely, we're closing our books this year.
We'll be north of a billion five in revenues.
We're a larger organization, again,
been around in our current kind of iteration
for almost a decade, as you and I mentioned before.
We're at about 80,000 locations across the US
on the provider side.
So I think of that as our supply, if you will,
and that's massive hospital systems
all the way down to critical access hospitals
in rural communities.
And then we have 350 real-world data partners.
And so all that's the supply.
And then on the demand side,
we have payer, life sciences,
and legal and attorney are big kind of verticals
that we serve.
We obviously do patience as you alluded to,
but we don't charge money for that.
And we are the number one player
in each one of those markets.
Serving, you know, I can confidently say
the majority of all of the demand side
requests from those segments come from us,
even if it's not us on the supply side, right?
So we'll go work with a hospital trying to run
their, you know, data exchange on their own
and help them digitize even if we're not staffing
and running the whole thing for them.
- Okay, let's talk about data.
I have like an entire chapter of my upcoming book
on data and the fact that we have this really odd problem
of data being both misused and underused in healthcare.
So I want to talk about both of those things,
starting with misuse.
And when I say that healthcare data is misused,
I mean, very literally misused as in stolen.
We all remember when United Health paid $20,000.
$22 million in Bitcoin ransom to Russian cyber criminals after their cyber attack shut down
their operations at clinics and pharmacies for over a week and it up costing the company
over two billion and that stolen data for all we know is like still out there.
Why is the healthcare sector such a prime target for cyber criminals?
Yeah, I would say three things.
One is the value.
The ability to grab health data, it's more valuable than credit card data, you know, it's
one of those areas where your willingness to pay exceeds your capacity to pay and so
if you have the ability to market or know what individuals are going through, like it's
wildly valuable to a whole bunch of stakeholders like out there and many of them, especially
in, you know, other areas of the world are willing to pay for that data where there's
less privacy and less IP controls, etc.
There's a lot of value, number two, wildly antiquated systems, you know, I joke with
Jeff all the time, like you don't even have to be a great technologist in healthcare to
make a hell of an impact because the bar is so low with so much of the legacy infrastructure
that's come across and I think that a few things cause that to happen.
One, I think HIPAA regs are very, very, very, that's a very high bar and we need to re-look
at HIPAA as a society and I can tell you like having work with providers for a very long
time.
If you put a HIPAA waiver in front of a patient, they sign it like every time, right?
So what really are we solving for and so I think we need to bottoms up, you know, what
HIPAA is and have it keep pace with technology and the change in some of the work we're talking
about and I think it's constrained systems more than helped them because it's not actually
solving the root underlying problem.
The second thing I would say is because of the way healthcare data moves around and
is stored, you know, in all these stored procedures and legacy systems and legacy infrastructure
across the environment, it is very hard to actually quantify risk and so a big thing that
we do with all of our clients is we, you know, spend north of $50 million a year on with
our CSO, our chief information security officer and his team going out, not only secure in
our own infrastructure but doing that with our clients as well and if I had to tell, you
know, you or anybody what we ultimately sell, it is trust and security, right?
They're removing very sensitive, very expensive, very valuable data around and it's something
that we take very seriously but unfortunately, like I think until we push and mandate and
I think high trust has been a good foundational movement, you know, more of a federal level.
This is where I get frustrated when I see the government waning on things like Tefka
and interoperability standards and regs, like put incentives in market and drive behavior
but let's ramp up penalties for information blocking, let's ramp up penalties for cybersecurity
breaches, right? Like put out incentives that will drive behavior and allow innovation
in the market. Me and my team spent a lot of time in DC pushing and showing and demonstrating,
you know, paths forward. The last thing I'll say technology has caught up in a big way.
The technology sector has figured out the healthcare is 25% at GDP, Amazon when I was
at Athena, AWS, you couldn't get them to sign a BAA, business associates agreements.
You could store PHI securely inside an Amazon environment. They do that at scale, you
know, now today. Another, yeah, acquiring companies and the billions for, yeah, yeah, in
the space. Cloud strikes, got a big healthcare presence, Databricks, Snowflake, you know,
all these organizations have come in. So the infrastructure is available now, which was
not the case, certainly not 10, but not even really five years ago. There needs to be
a big modernization effort of a lot of these legacy technology platforms that sit out
there. And I think that, you know, Optimus, a very large client of ours, like they're
going through that at scale after the change breach that you just mentioned and have been
spending more money than ever attacking that problem.
Getting up to face. Okay. So you said we need to relook at HIPAA. What would you, what
would you recommend is change to updated? Yeah. Look, I mean, not, not tooting our own
horn. And there's other options out there, but tokenization and like these concepts of
privacy, enhancing, linking technologies did not exist or even formulated when HIPAA
was originally constructed, right? And it's, I think it's, every time I've gone to DC,
you get consumer advocacy groups pushing HIPAA at a million foot level without getting
to the nuance of technology change. And I think we've got to bridge the gap there and
make it to where we take a look and do a refresh, probably regulate a refresh of HIPAA
every so often, given how fast the pace of technology, technological change, you know,
is happening to market. You know, the other thing that I think we have to improve federal
coordination and communication of cybersecurity incidents and near misses, like when one or
two records go out or, you know, it's going to happen, right? Like we need to, you can't
protect everything and we need to make it so folks feel comfortable and safe, especially
some of these hospitals and other organizations who don't have all the resources necessary
to do all the upgrades I'm talking about. And federally fond of the ability to start
to upgrade our infrastructure, I think it's a national security conversation. This is
not just a nice to have. We need to start treating it as such.
And you think it can change with the current administration?
Yeah. I think it can change. I think it's, you know, the good thing about healthcare
data and healthcare data regs, it has transcended many Democratic and Republican administrations.
No one's going to argue with you against it. The bigger problem though is you need probably
an eight-year admin to get some of the changes pushed through because there's so much turnover
inside CMS and CMMI and some of the other vehicles right now. But a lot of the staffers
and folks have been there for some time are moving the ball forward in a great way. And
I think that, you know, we've had more conversations with the federal government in the last two
years or so since I've been here, FDA, CMS, you know, HHS all over the map, with them
starting to think about more modern tech and going out and reaching out to constituents
to start to answer this problem, you know, that you and I are laying out right now.
Yeah.
So, okay, back to the data misuse and underuse problems. So underuse, there are some estimates
that about 97% of healthcare data remains untapped because it's in isolated, unstructured networks,
closed ecosystems. This is obviously like the core of your mission and what you're doing.
In your view, where is healthcare leaving the most value on the table when it comes to
data?
Yeah. It's so much of it, you know, the number one in my view is just the way we capture
information, right? And so if you've got a medical record system that is predominantly designed
for billing, it is going to be billing focused on the inputs and outputs, right? It's
word about coding and it's word about reimbursement. And so the other information that's captured
largely goes into an unstructured bucket and it sits there and it's very hard to clean
it up. It's very hard to transfer it if you switch general practitioners if you're going
to a specialist. Next, you have imaging and imaging systems are largely disconnected from
this stream of data that I'm mentioning and they're very valuable. I do believe the very
strong use case of artificial intelligence is going to be at the very least summarizing
all this information and a clean concise, you know, statistically significant way where
a clinician or a lab tech or whoever on the healthcare delivery supply chain can have
better information at their fingertips. The other top of mind thing for me is the med list,
right? One of the things we did it signify, we would go into these predominantly seniors
homes and say, all right, give me everything you're taking. Get it meet from, you know,
the bathroom, medicine cabinet, get it from the fridge, your bedside table, like let's lay
it all out. And that was the best med list ever, right? Because it wasn't what they were
prescribed. It wasn't what they remember to bring to the doc. It was like what they were
actually doing. And we got to see seniors splitting pills because they were their digestive
system or they couldn't afford the full pill every day. And so that's like a real med list.
Getting closer to that from a consumer centric standpoint at scale is absolutely critical
for us bending the cost curve and driving, you know, better outcomes. And reimbursement
centric medical record does not have that at the heart of its, you know, mission or charge.
And so again, like if I was running CMS for a day, like figuring out incentives and vehicles
to get that level of med list, like pulled together and with consent and authorization spread
to providers, drug on drug interaction and all the other drug issues I just mentioned are
huge things that go really untouched. And pharmacy has been largely pushed out of the kind
of central care team, you know, historically that's starting to change in a lot of places.
But tackling that problem, I think, is one that does not get talked about enough.
No, it really doesn't. And do you feel like that is more possible within like a value-based
care world where if your patient population is under a capitated model, you have more
incentive to kind of track at more of a patient centered level?
I don't even know what value-based care means anymore. Like unfortunately, like, I, you're
not being paid for, you're, you're being paid a flat-capitated fee to manage a patient
population.
In that case, you would imagine a billing-based EHR isn't as important as one that is like
clinically more relevant.
The problem is all the EHRs, especially the ones at any desospitals are so billing-centric.
Like, you put, so what do you do? You buy wrapper software like Arcadia and others that
sit around the whole thing.
and it's logging in at different screens.
You've got an overlay.
I just don't think it's been cracked at its core.
And I'm a broken record on this.
This, you know, the new models that are coming out right now,
they're not paying off money to primary care physicians period.
And you're not going to get behavior change
until you rip the bandaid on incentives
and drive alignment downstream.
And we are too scared as a society with negative incentives
and influencing behavior and all these other things.
And instead of actually taking more risk and pushing an agenda,
that is patient-centric, which is what you're articulating,
I think we've gotten ourselves wrapped up
in a constraint-centric point of view
versus taking risks and experimenting with reimbursement,
you know, in particular, to see how we can drive better change.
But the systems are a real constraint.
The systems of record are real constraint inside of that today.
No, absolutely.
And as you talk about being, like, focused more on reimbursement and billing,
like, of course, then the product is, you know, health data
that is about billing codes, and not necessarily about, like,
the actual patient experience, is there--
I'm just, like, brainstorming out loud here with you.
Now, the proliferation of ambient scribes,
we are capturing more of the encounter
than we have ever done before.
Do you think that could be a push in the right direction for having data?
That's, like, a little bit more able to be parsed
and inclusive of clinical information
that doesn't exist today, or doesn't exist yesterday?
I wish I could say yes without a doubt.
I'm hopeful, is what I would say.
But I, you know, as I've gotten the ground
and spent some time around the ambient space,
like, first of all, transcription and scribing
has been allowed around for a very long time.
And there's people that were physically listening
into the encounter and just typing it out.
And like-- Oh, yeah. We backed dog medics at Rock Health.
Yeah, and they were very early to this space.
And so I've seen it around.
When I sit with docs, and I do it frequently,
because we're, like, so deep in the workflow,
and we work with them, they've got macros.
They're copying and pasting.
Like, their method of data entry is very efficient,
depending on the encounter.
And so I'm not sure there's going to be some--
and if you really peel back utilization statistics
on the various ambient providers, they're all over the place.
And it's a very specialty centric.
It's very health system centric.
And do I think it makes the doctors feel better without a doubt?
I mean, look at the growth and the kind of explosion
in that space, like without a doubt--
The adoption is incredible.
Yeah. But is it going to solve the problem
you're talking about?
I think we need more time.
Is the answer to it.
And I think, look, like, that space is under a lot of pressure.
You've got Epic and Athena basically saying,
and others, we're going to do this for free.
Like, this is going to be a part of our, you know,
native EHR system now, which puts all of the third parties
like in the space and a really interesting space.
So if the price goes to zero, where do they
need to get the money from?
It has to be the payers, life sciences, other providers.
You need that information.
Like, you've got to go back out to the ecosystem.
But the second you do that, you're putting
more administrative burden back in the dark, right?
Because they're needing to think about another billing code
or another clinical trial enrollment
or whatever it might be.
And so it's not a problem that I think is an easy solution.
I'm very hopeful, though, that space is the path forward
to taking some of that documentation burden off of providers,
because they spend an awful lot of time, you know, on this.
Oh, yeah.
Let's talk about your job.
Being CEO is the hardest.
And in my opinion, the worst job.
You're clearly very, very good at it.
What part of the job do you love the most?
I'd say it's two things.
I love rolling up my sleeves and getting out
with the customers and putting a headset
on like sitting in the medical record room,
understanding with the discovery team
and our life sciences client, how they're recruiting patients
and where they're running into problems.
Like, and I push on my team constantly,
that direct, especially in healthcare,
like customer experience.
Like, there is no shortcut.
And no two organizations are the same.
And so you have to physically spend time
and re-implement yourselves.
Like, you can't launch a product in healthcare
or expect it to be static.
Like, you have to be on some routine cadence
of updating and reintegrating
and changing is just a constant, like, inside this space.
So I love that.
And two, I love my teams.
Like, and I mentioned, so many of them
have come from outside of healthcare backgrounds.
And so many of them have been with me for some time.
And, you know, I've enjoyed a lot of the folks
that when I was younger in my career,
I had a lot of great mentors and people invested in me.
I love doing that with folks now too.
And I try to design my organizations
and create them when we scale
to still have that kind of human-centric
mentoring and nurturing model at their core.
And I think when all those things are happening,
like, you have fun.
And I think having fun at work is super important
because there's especially in healthcare, a lot of chaos
and challenges on an everyday basis that you face.
Yeah, I think people, especially MBAs like us,
you know, the role is like romanticized to us.
Or it's almost assumed like the CEO
is that goal for you in your career.
But it's really not a job for everyone.
What would you say to people kind of early in their career
who are thinking about their trajectories
of the companies that they're working at or starting?
Yeah, it's the most full-time job there is.
Like, I think you have to be willing.
I say so my management teams too.
Like, we are responsible for a massive pool of consumers
in healthcare organizations and healthcare is 24/7.
And there's sometimes like your joy is going to have to be on.
You can't just close the laptop
and just ignore what's going on.
And so that's a sacrifice, right?
And that's a decision that has to be made.
Two, and my father-in-law loved this.
He was a professor at HBS for a long time.
He was very early on in the organizational behavior unit.
But it's a whole bunch of people management, right?
And people are complicated and it's messy and they're emotional
and they have their own priorities and their own lives.
And so I think leading with heart and paying attention
to folks and their motivations and what they're trying to do,
both clients and employees, it's a lot.
And if you are not up for that type of engagement,
I think real success is tough.
There's a lot of CEOs that just choose to sit on top
and do not do the two things I talked about.
And there's a very different organizations.
I think that have very statistically different outcomes.
And I think that leading in a human centered way
like that, both with clients and with your individuals
you work with is super important.
Yeah, I actually found that out as CEO
that the people management piece was not congruent
with what I was good at or what I wanted to do.
I wanted to do the work.
I enjoy doing the work.
I love thinking through the problems.
I love getting my hands dirty and solving the problems.
But actually as CEO, you spend most of your time
on people management.
And if that is not your thing,
if it is not your biggest skill,
then you're probably not the right one for the job.
You've now let a company through IPO and acquisition
and acquiring companies.
Most CEOs don't get those privileges.
Given those two experiences, IPO, the acquisition,
which one was actually harder to navigate?
The IPO without a doubt.
Public markets are the wild west.
And we beaten raised our financial projections
every single quarter that I was CEO.
And just an amazing team.
And our stock went from $40 to $11 during that time.
So like almost a 4X, like Delta.
And it's very amazing.
Due to the market sentiment,
due to the development of your company's public.
And some of them shouldn't have been companies.
Some of them should have American public.
Some of them are never going to make money.
And so who to compare you to is big when you're public.
And that's very hard to educate employees on.
All your metrics are green and going up.
And everyone's working so hard.
So it's a very tough spot to be in managing a team.
I actually think public markets are more designed
for large diversified businesses.
And businesses that are more well known
and understood kind of in market.
Or something that's truly breakout disruption,
like this whole AI craze that's going on right now,
where there's so many data points and use cases and examples.
I think public investors need more of that.
And so I'd say that volatility was way harder
to deal with than the acquisition.
The acquisition was a lot.
Like I don't want to downplay it.
We had 21 folks bid on signify.
I lived in a hotel room for weeks in New York.
Just dry cleaning my clothes.
Going back to Goldman Sachs every morning.
Like it was the Groundhog Day repeating myself.
Oh, Lincoln Mush.
But CVS was a great place to land.
An amazing management team.
They're still a very large customer of ours.
And I had a great time there.
I spent almost two years there, learned a ton.
And believe they've got a great platform
to help really improve the consumer experience
ultimately in healthcare.
And so I was very happy to signify the land there.
It's where I wanted to signify the land
of all the folks that were out there.
And we'll say even those great financial outcome,
like when came to the crossroads of deciding,
like it's a very personal decision
for you as someone who's worked at a business so long.
And all the employees and all the customers
and all those relationships of where things to land.
And at the end of the day, there's things matter, the most.
And so it was very happy to see CVS continue
to invest in signify.
And we beat every number.
We told them we would deliver them.
And it's a part of my and the team's reputation.
And that matters a lot.
Totally.
Yeah.
So Kyle, this has been a great conversation.
I always like to end the show by asking people
if they could wave a magic wand and change one thing
about healthcare, what would it be?
I think for me, it would be having incentives really changed.
And ensuring that, let's define--
the behavior we want, whether it's information sharing or as you alluded to a more value-based
centric approach where payment and risk and clinical information is all bundled into
one infrastructure buildout, whatever those things are, I think we need to be way more bold
at experimenting and relax some historical notions of technology and alignment and market
players if we're going to get out of this current, frankly, mess that we're in, right?
The Medicare Trust is in distress, period, and we've got providers that are burned out,
and if we're going to get past that, we've got to really start thinking outside of the
box.
I'm hopeful CMMI can get there again.
I feel like under Patrick Conway, there was an explosion of innovation and new models
coming out.
The ability to price things and to transparently price things, I should say, is difficult because
of system limitations and a whole bunch of other factors internally, we've got to strip
those things away, because it's keeping capital and innovation away from those programs
today.
I look to governments the largest pair in the United States, and it will be forever, and
we need to make sure that we keep removing constraints around its ability to innovate
as well.
Yep.
Awesome.
Well, Kyle, thank you for your time today.
It was great to see you.
Yeah, great to see you too, take care.
Thanks for listening to The Heart of Healthcare.
If you enjoyed this episode and you'd like to support the podcast, please leave a rating
and review, and don't forget to subscribe.
The Heart of Healthcare is produced by Halle Teco and hosted by Michael Eskivell, Steve
Kraus, and Halle Teco.
The show is engineered, edited, and mixed by Kyle Moore.
Visit our website heartofhealthcarepodcast.com for show notes and details.
Podcast Summary
Key Points:
Kyle Armrester, CEO of DataVont, leads the largest health data ecosystem in the U.S., solving long-standing administrative inefficiencies by enabling secure, real-time clinical data exchange.
DataVont eliminates legacy data silos and fragmentation by acting as a neutral, consent-based digital intermediary between providers, payers, life sciences, and legal entities.
The company digitizes clinical data from over 80,000 U.S. healthcare locations and connects to 350 real-world data partners, transforming fragmented data into actionable, interoperable insights.
A core mission is reducing administrative burden by moving data processing upstream—before billing—through automated clinical data validation and editing, such as in SmarterDX’s value chain work.
Healthcare data is both misused (due to outdated systems and weak cybersecurity) and underused (97% remains untapped), with DataVont addressing both by promoting secure tokenization and patient-centered data access.
The company emphasizes trust, security, and patient data ownership, ensuring data stays within clients’ native systems and is only shared with explicit consent.
Kyle advocates for a fundamental overhaul of HIPAA and federal cybersecurity policies to better align with modern technology and patient-centered care models.
He believes healthcare must shift from billing-centric EHRs to clinically relevant systems and embrace innovation like ambient scribing to improve data quality and provider well-being.
Summary:
Healthcare remains a uniquely inefficient industry, riddled with administrative chaos, data silos, and opaque billing processes. Kyle Armrester, CEO of DataVont, addresses this through a scalable, secure, and patient-centric digital health data ecosystem. DataVont bridges clinical data gaps across providers, payers, life sciences, and legal firms by acting as a neutral, consent-driven intermediary, enabling real-time, interoperable data exchange without storing or monetizing data.
This digital transformation reduces administrative burden by shifting data processing upstream—before claims are generated—allowing early clinical insights and better care coordination. With over 80,000 provider locations and 350 data partners, DataVont is now a central hub for health data. The company also tackles critical issues like data misuse and underutilization, driven by antiquated systems and weak cybersecurity.
Kyle argues for urgent reforms to HIPAA and federal regulations to modernize data governance and incentivize patient-centered innovation. He highlights that value-based care and clinical EHRs must shift from billing-focused to patient-centered models, and that emerging tools like ambient scribing hold promise but require deeper integration and trust. Ultimately, the future of healthcare depends on dismantling systemic constraints, fostering trust, and aligning incentives—especially through bold policy and market innovation—to deliver better outcomes and reduce burnout.
FAQs
DataVont solves the issue of fragmented and inefficient healthcare data exchange by creating a secure, real-time digital platform that connects clinical data across providers, payers, life sciences, and patients, eliminating administrative burdens and enabling seamless data sharing.
Unlike legacy systems focused on billing and coding, DataVont provides real-time, interoperable clinical data with a patient-centric, secure, and consent-based approach, allowing data to flow freely across the healthcare ecosystem without compromising privacy or compliance.
Key benefits include reduced administrative costs, faster data access for providers and payers, improved patient care through better data visibility, and the elimination of outdated processes like fax machines and manual record transfers.
DataVont ensures privacy by storing data in clients' native systems, using strict consent authorization, and applying de-identification techniques. It also partners with leading cloud providers like Snowflake and AWS to maintain secure, compliant data transmission.
DataVont tackles data misuse by securing sensitive information against cyberattacks and addresses underuse by unlocking 97% of untapped data through real-time, structured, and accessible clinical data that can be used for research, quality programs, and treatment decisions.
DataVont provides patients with a free, user-friendly digital interface to access their medical records, allowing them to securely transfer records when changing providers or hospitals, improving patient engagement and continuity of care.
Chat with AI
Loading...
Pro features
Go deeper with this episode
Unlock creator-grade tools that turn any transcript into show notes and subtitle files.